Novozymes North America Inc
77 Perry Chapel Church Road
General E-mail: firstname.lastname@example.org
Web Address: www.novozymes.com
Executive Officer: Peder Holk Nielsen, President
Organization's Purpose or Mission:
Novozymes’ business is industrial enzymes, microorganisms, and biopharmaceutical ingredients. Novozymes helps companies make more from less by offering solutions that save energy and raw materials, and reduce waste. The result is higher quality products, lower costs, and a better environment. Its biological solutions are used in the manufacturing process of numerous products including biofuels, detergents, food, and animal feed.
In 2012, Novozymes’ portfolio contained more than 700 products sold in 130 countries worldwide. The company’s never-ending exploration of nature’s potential is evidenced by over 7,000 patents, showing what is possible when nature and technology join forces. Novozymes employs more than 6,000 globally, including more than 1,100 in North America.
Novozymes uses biotechnology to challenge convention and find sustainable solutions. The company asks the world to “Rethink Tomorrow.” Novozymes’ solutions are based on a unique technology platform that provides a wealth of opportunity for the world’s industries. Gene technology, microbial techniques, and fermentation technology are some of the biotechnological tools which form the base of the business. Combining industrial insight with this technology platform, Novozymes partners with customers across more than 30 industries to create tomorrow’s industrial biosolutions that not only safeguard the use of our planet’s resources but also improve its customers’ business. Read more at www.novozymes.com.
Services or Products Description:
Industrial enzymes, microorganisms, and biopharmaceutical ingredients
Corporate History and Milestones:
Novozymes was founded in 2000 in a demerger from pharmaceutical company Novo Nordisk. Novozymes’ roots date back to the 1920s when Novo Terapeutisk Laboratorium and Nordisk Insulinlaboratorium were established in Copenhagen, Denmark. Enzyme production began in 1941.
Sustainability is an integral part of the business, and Novozymes enables its customers to optimize their use of raw materials and energy, thereby reducing the environmental impact of their operations. In 2012 alone, the worldwide application of Novozymes’ bioinnovation enabled reductions in CO2 emissions of approximately 48 million tons. It is our ambition to enable a 75 million ton reduction in CO2 emissions in 2015. Novozymes is industry leader of the biotechnology sector in the Dow Jones World and STOXX Sustainability Indexes. Novozymes has achieved the SAM Gold Class rating in 2010, 2011 and 2012.
Traded Publicly: NASDAQ OMX
Stock Name: NZYM (COP)